Abstract
Synthetic studies on new antitumor drugs in Japan are being mostly oriented to search for new analogs of the known antitumor drugs, although a few compounds having original chemical structure are also under investigation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aoshima, M., Sakurai, Y.: Comparative studies on the antitumor activity and the bone marrow toxicity of l-(β-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose. Gann 68, 247–250 (1977).
Aoshima, M., Tsukagoshi, S., Sakurai, Y., Ohishi, J., Ishida, T., Kobayashi, H.: Antitumor activity of newly synthesized N4-acyl-l-β-D-arabinofuranosylcytosine. Cancer Res. 36, 2726–2732 (1976).
Aoshima, M., Tsukagoshi, S., Sakurai, Y., Ohishi, J., Ishida, T., Kobayashi, H.: N4-Behenoyl-1-β-D-arabinofuranosylcytosine as a new potential antitumor agent. Cancer Res. 37 (in press) (1977).
Arakawa, M., Shimizu, F.: Effect of 3-(amino-2-methyl-5-pyrimidinyl)-l-(2-chloroethyI)-nitrosourea hydrochloride on lymphoid leukemia L1210. Gann 66, 149–154 (1975).
Arakawa, M., Nakao, H., Aoki, T.: Effect of carbazilquinone on transplantable and primary tumors in mice. Gann 61, 535–539 (1970).
Arakawa, M., Shimizu, F., Okada, N.: Effect of l-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on leukemia L1210. Gann 65, 191 (1974).
Connors, T. A., Cox, P. J., Farmer, P. B., Foster, A. B., Jarman, M.: Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem. Pharmacol. 23, 115–129 (1974).
COOPERATIVE STUDY GROUP OF PHASE I STUDY ON ACNU: Phase I study of l-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU). Jap. J. Clin. Oncology 6, 55–62(1976).
El-merzabani, M. M., Sakurai, Y.: A new alkylating agent effective to experimental tumors resistant to nitrogen mustard. Gann 56, 589–594 (1965).
El-merzabani, M. M., Sakurai, Y.: Anticancer activity of methanesulfonic acid esters of aminoglycols against mouse leukemia L1210. Gann 58, 199–203 (1967).
Fox, P.A., Panasci, L. C., Schein, P.: Biological and biochemical properties of 1-(2-chloroethyl)-3-(β-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity. Cancer Res. 37, 783–787 (1977).
Fujita, H., Ogawa, K., Kato, A., Kitazato, K., Yasuda, A., Kimura, K.: Pharmacokinetics of new masked type fluorinated pyrimidines; FD1 FD2 and FDx. Proc. Jap. Cancer Assoc, The 35th Annual Meeting, p. 123 (1976).
Hirayama, H., Sugihara, T., Hamada, F., Kanai, T., Hikita, J., Araki, Y., Kuretani, K., Hoshi, A.: Distribution and excretion of cyclocytidine in monkeys, dogs, and rats. Gann 65, 153–161 (1974).
Hoshi, A., Kanzawa, F., Kuretani, K.: Antitumor activity of cyclocytidine in a variety of tumors. Gann 63, 353–360 (1972).
Iwasaki, M., Sekido, S., Ninomiya, K., Serine, J., Ueno, S., Nagamatsu, Y., Kimura, G.: Antitumor activities of 3-methyl-α-D-glucopyranos-6-yl)-l-(2-chloroethyl)-l-nitrosourea. Gann 67, 137–139 (1976).
Kidani, Y., Inagaki, K., Tsukagoshi, S.: Examination of antitumor activities of platinum complexes of 1,2-diamino-cyclohexane isomers and their related complexes. Gann 67, 921–922 (1976).
Machinami, T., Kobayashi, K., Hayakawa, I., Suami, T.: Synthesis of sugar derivatives of N-alkyl-N-nitrosourea. Bull. Chem. Soc. Jap. 48, 3761–3762 (1975).
Machinami, T., Nishiyama, S., Kikuchi, K., Suami, T.: Synthesis of (2-chloroethyl)-nitrosourea derivatives of carbohydrate. Bull. Chem. Soc. Jap. 48, 3763–3764 (1975).
Morimoto, K., Yamaha, T., Nakadate, M., Suzuki, I.: Biochemical studies on 1,1-ethylenebis (1-nitrosourea) (EBNU). I. Degradation of EBNU in mild conditions. Chem. Pharm. Bull. (Tokyo) 25, 151–157 (1977).
Nakadate, M., Anzai, M., Suzuki, I., Ishidate, Jr., M., Odashima, S.: Carcinostatic effect of 1, 1′-polymethylenebis-(1-nitrosourea) on AH 13 and L-1210 cells. Gann. 64, 415–416 (1973).
Salto, T., Ogira, S., Wakui, A., Yokoyama, M., Takahashi, H., Himori, T., Kudo, T., Maezawa, S., Ujiie, S., Sugawara, N.: Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679). Cancer Chemother. Rep. 57/1, 447–457 (1973).
Takamizawa, A., Matsumoto, S., Iwata, T., Katagiri, K., Tochino, K., Yamaguchi, K.: Studies on cyclophosphamide metabolites and their related compounds. II. Preparation of an active species of cyclophosphamide and some related compounds. J. Am. Chem. Soc. 95, 985–986 (1973).
Takamizawa, A., Yamaguchi, K., Shiratori, O., Kasai, H., Uchida, N., Satoh, H., Ichikawa, H.: Relationship between antitumor activity and functional groups of 4-hydroperoxy-cyclophosphamide (40487) analogues. Proc. Jap. Cancer Ass., The 35th Annual Meeting, p. 117 (1976).
Unemi, N., Yasumoto, M., Morita, K., Kajihara, M., Toide, H.: Antitumor effects of new 5-FU derivatives. Proc. Jap. Cancer Ass., The 35th Annual Meeting, p. 132 (1976).
Wempen, I., Miller, N., Falco, E. A., Fox, J. J.: Syntheses of some N4-substituted derivates of 1-β-D-arabinofuranosyl-cytosine and 5-fluorocytosine. J. Med. Chem. 11, 144–148 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Sakurai, Y. (1978). Synthetic Analogs of Antitumor Drugs Under Development in Japan. In: Carter, S.K., Umezawa, H., Douros, J., Sakurai, Y. (eds) Antitumor Antibiotics. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81219-4_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-81219-4_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81221-7
Online ISBN: 978-3-642-81219-4
eBook Packages: Springer Book Archive